| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoplasmic Reticulum Stress | 15 | 2024 | 85 | 3.940 |
Why?
|
| Endoplasmic Reticulum | 16 | 2024 | 255 | 3.920 |
Why?
|
| Unfolded Protein Response | 12 | 2024 | 43 | 2.370 |
Why?
|
| Endoribonucleases | 11 | 2023 | 92 | 1.710 |
Why?
|
| Pancreatic Neoplasms | 4 | 2024 | 669 | 1.620 |
Why?
|
| Mitochondria | 10 | 2015 | 553 | 1.530 |
Why?
|
| Apoptosis | 18 | 2015 | 1717 | 1.530 |
Why?
|
| Homeostasis | 5 | 2024 | 415 | 1.200 |
Why?
|
| Stress, Physiological | 2 | 2024 | 231 | 1.150 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 540 | 1.040 |
Why?
|
| Signal Transduction | 12 | 2024 | 3376 | 1.000 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 7 | 2015 | 196 | 0.940 |
Why?
|
| Pancreas | 3 | 2024 | 246 | 0.930 |
Why?
|
| eIF-2 Kinase | 2 | 2024 | 48 | 0.920 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 604 | 0.820 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 80 | 0.750 |
Why?
|
| Caspase 2 | 2 | 2012 | 9 | 0.740 |
Why?
|
| Animals | 36 | 2024 | 27330 | 0.710 |
Why?
|
| Calcium | 7 | 2022 | 1174 | 0.700 |
Why?
|
| Pancreatic Elastase | 1 | 2019 | 15 | 0.690 |
Why?
|
| Pancreatitis | 1 | 2019 | 86 | 0.650 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 101 | 0.640 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 6 | 2010 | 12 | 0.600 |
Why?
|
| bcl-2-Associated X Protein | 6 | 2010 | 46 | 0.590 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 118 | 0.590 |
Why?
|
| Proteostasis Deficiencies | 1 | 2016 | 3 | 0.570 |
Why?
|
| Mice | 24 | 2024 | 11743 | 0.520 |
Why?
|
| fas Receptor | 1 | 2015 | 77 | 0.510 |
Why?
|
| Neoplasms | 3 | 2022 | 3037 | 0.500 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1194 | 0.490 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 198 | 0.490 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 258 | 0.480 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 217 | 0.440 |
Why?
|
| Motor Neurons | 2 | 2014 | 174 | 0.430 |
Why?
|
| Mutation | 8 | 2022 | 4137 | 0.430 |
Why?
|
| Pancreas, Exocrine | 2 | 2023 | 18 | 0.430 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 3 | 2011 | 13 | 0.430 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2014 | 187 | 0.430 |
Why?
|
| Pancreatic Diseases | 2 | 2023 | 53 | 0.420 |
Why?
|
| Cysteine Endopeptidases | 1 | 2012 | 88 | 0.410 |
Why?
|
| Oncogene Protein v-crk | 1 | 2011 | 1 | 0.410 |
Why?
|
| Liver | 1 | 2017 | 1205 | 0.400 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 50 | 0.400 |
Why?
|
| MicroRNAs | 2 | 2014 | 551 | 0.380 |
Why?
|
| Humans | 40 | 2024 | 89157 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2338 | 0.360 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 548 | 0.350 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1521 | 0.350 |
Why?
|
| Up-Regulation | 4 | 2019 | 727 | 0.280 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 739 | 0.260 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 1997 | 17 | 0.250 |
Why?
|
| Membrane Proteins | 5 | 2014 | 1215 | 0.250 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 2553 | 0.240 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 122 | 0.240 |
Why?
|
| Cytoplasmic Granules | 1 | 2024 | 96 | 0.230 |
Why?
|
| Cells, Cultured | 10 | 2014 | 2880 | 0.230 |
Why?
|
| CDC2 Protein Kinase | 2 | 2015 | 46 | 0.230 |
Why?
|
| Calcium Channels | 1 | 2004 | 182 | 0.220 |
Why?
|
| Retinitis Pigmentosa | 1 | 2023 | 35 | 0.220 |
Why?
|
| Retinal Degeneration | 1 | 2023 | 29 | 0.220 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 10 | 0.210 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1574 | 0.210 |
Why?
|
| Calreticulin | 1 | 2022 | 13 | 0.210 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 1224 | 0.210 |
Why?
|
| Tripartite Motif Proteins | 1 | 2022 | 3 | 0.210 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2022 | 5 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2011 | 755 | 0.200 |
Why?
|
| HEK293 Cells | 3 | 2014 | 638 | 0.200 |
Why?
|
| Models, Biological | 4 | 2016 | 1764 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 1997 | 307 | 0.200 |
Why?
|
| Glioma | 3 | 2014 | 293 | 0.190 |
Why?
|
| Interleukin-4 | 3 | 1997 | 130 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2022 | 429 | 0.180 |
Why?
|
| Parkinson Disease | 1 | 2022 | 146 | 0.180 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 132 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 470 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2363 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 236 | 0.170 |
Why?
|
| Adenine | 1 | 2019 | 88 | 0.170 |
Why?
|
| Problem Behavior | 1 | 2019 | 8 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 559 | 0.160 |
Why?
|
| Phosphorylation | 6 | 2022 | 1130 | 0.160 |
Why?
|
| B-Lymphocytes | 4 | 1997 | 738 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2022 | 477 | 0.160 |
Why?
|
| Mutant Proteins | 2 | 2022 | 96 | 0.150 |
Why?
|
| Choroid Neoplasms | 1 | 2017 | 6 | 0.150 |
Why?
|
| Interleukin-2 | 3 | 1997 | 251 | 0.150 |
Why?
|
| Indoles | 1 | 2019 | 312 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1990 | 0.150 |
Why?
|
| Cell Survival | 1 | 2019 | 982 | 0.140 |
Why?
|
| Milk Proteins | 1 | 1996 | 24 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2014 | 698 | 0.140 |
Why?
|
| Virus Replication | 2 | 2022 | 321 | 0.130 |
Why?
|
| X-Box Binding Protein 1 | 3 | 2022 | 16 | 0.130 |
Why?
|
| Cell Line | 7 | 2015 | 2495 | 0.130 |
Why?
|
| Ribonucleases | 4 | 2022 | 93 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2015 | 37 | 0.120 |
Why?
|
| Cell Self Renewal | 1 | 2014 | 20 | 0.120 |
Why?
|
| RNA Stability | 2 | 2012 | 89 | 0.120 |
Why?
|
| Teratoma | 1 | 2015 | 51 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 32 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 71 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2014 | 34 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 96 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2022 | 1652 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 31 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2012 | 519 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1265 | 0.110 |
Why?
|
| Endosomes | 1 | 2014 | 79 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2014 | 681 | 0.110 |
Why?
|
| Students, Medical | 1 | 2019 | 418 | 0.110 |
Why?
|
| Cell Line, Transformed | 2 | 2011 | 155 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2014 | 177 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1650 | 0.110 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 116 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 387 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2007 | 669 | 0.110 |
Why?
|
| Brefeldin A | 1 | 2012 | 10 | 0.110 |
Why?
|
| Cell-Free System | 1 | 2012 | 51 | 0.110 |
Why?
|
| Regulatory Factor X Transcription Factors | 2 | 2012 | 11 | 0.110 |
Why?
|
| Thioredoxins | 1 | 2012 | 13 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2012 | 25 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 94 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 447 | 0.100 |
Why?
|
| Inflammasomes | 1 | 2012 | 26 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2022 | 2011 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 414 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2011 | 27 | 0.100 |
Why?
|
| Purines | 1 | 2012 | 93 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2011 | 11 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2011 | 77 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2014 | 265 | 0.100 |
Why?
|
| Interferons | 2 | 2022 | 124 | 0.100 |
Why?
|
| Caspases | 1 | 2011 | 155 | 0.100 |
Why?
|
| Furans | 1 | 2010 | 16 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 665 | 0.090 |
Why?
|
| Protein Unfolding | 1 | 2010 | 13 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 21 | 0.090 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2010 | 48 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 388 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1241 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 740 | 0.090 |
Why?
|
| Proteins | 1 | 2015 | 786 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 262 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 187 | 0.080 |
Why?
|
| Autophagy | 1 | 2010 | 159 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 315 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 781 | 0.080 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2004 | 29 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2010 | 373 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2007 | 47 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3211 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 1 | 2007 | 141 | 0.070 |
Why?
|
| Immune System | 1 | 2007 | 97 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2003 | 138 | 0.070 |
Why?
|
| Janus Kinase 3 | 4 | 1997 | 9 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 17 | 0.060 |
Why?
|
| Thapsigargin | 1 | 2004 | 55 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 394 | 0.060 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 1996 | 261 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2007 | 458 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2024 | 17 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 86 | 0.060 |
Why?
|
| Trans-Activators | 2 | 1997 | 443 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2024 | 195 | 0.060 |
Why?
|
| Rhodopsin | 1 | 2023 | 20 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2004 | 511 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 428 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 15 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2014 | 274 | 0.050 |
Why?
|
| Sphingosine | 1 | 2003 | 74 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2012 | 1088 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 41 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2022 | 26 | 0.050 |
Why?
|
| Mitochondria, Liver | 1 | 2002 | 28 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 102 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 83 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2022 | 71 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 2553 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2022 | 91 | 0.050 |
Why?
|
| Microtubules | 1 | 2022 | 123 | 0.050 |
Why?
|
| Female | 3 | 2022 | 46078 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 170 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 184 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2022 | 195 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 404 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 595 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 2 | 1997 | 28 | 0.040 |
Why?
|
| Janus Kinase 1 | 2 | 1996 | 16 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 1996 | 55 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2012 | 691 | 0.040 |
Why?
|
| San Francisco | 1 | 2019 | 24 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 92 | 0.040 |
Why?
|
| Feedback | 1 | 2019 | 134 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 1239 | 0.040 |
Why?
|
| Aging | 1 | 2023 | 716 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 335 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 688 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1996 | 7 | 0.040 |
Why?
|
| Retinal Detachment | 1 | 2017 | 66 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 299 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 67 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 1996 | 43 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 136 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 277 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2019 | 178 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 36 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1258 | 0.030 |
Why?
|
| Tyrosine | 1 | 1995 | 133 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 4041 | 0.030 |
Why?
|
| Cyclin B2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cyclin B1 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cyclin A | 1 | 2015 | 29 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Interleukins | 1 | 1995 | 129 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 82 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 794 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 51 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2014 | 23 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2015 | 232 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2014 | 40 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2014 | 100 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 63 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 376 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1996 | 370 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 201 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 218 | 0.030 |
Why?
|
| DNA Damage | 1 | 2015 | 371 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 275 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2012 | 96 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2753 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 87 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 23 | 0.030 |
Why?
|
| Retina | 1 | 2014 | 219 | 0.030 |
Why?
|
| Catalysis | 1 | 2012 | 205 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 82 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2011 | 117 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 267 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 282 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2012 | 152 | 0.020 |
Why?
|
| Chloroquine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 511 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2010 | 36 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2614 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 313 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 814 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 91 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 306 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 148 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 136 | 0.020 |
Why?
|
| Sirolimus | 1 | 2010 | 170 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 370 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 287 | 0.020 |
Why?
|
| Male | 4 | 2017 | 42309 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1798 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1975 | 0.020 |
Why?
|
| Insulin | 1 | 2009 | 1146 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1940 | 0.010 |
Why?
|
| Ionomycin | 1 | 2003 | 21 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 29 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 71 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 24 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 63 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 126 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 159 | 0.010 |
Why?
|
| Adenylate Kinase | 1 | 2002 | 13 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 117 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 510 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 565 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 237 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 645 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 25910 | 0.010 |
Why?
|
| Consanguinity | 1 | 1996 | 73 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1996 | 87 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 177 | 0.010 |
Why?
|
| Retroviridae | 1 | 1996 | 79 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 153 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 646 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 446 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 911 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1012 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 751 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3027 | 0.010 |
Why?
|
| Child | 1 | 1996 | 7154 | 0.000 |
Why?
|